Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Borner

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|January 1, 1984
Comparative pharmacokinetics of apalcillin and piperacillinH Lode, A Elvers, P Koeppe, et al.
Clinical Pharmacology and Therapeutics|February 1, 1984
Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal functionD Kampf, K Borner, M Möller, et al.
Chemotherapy|January 1, 1990
Pharmacokinetics of ciprofloxacin in liver cirrhosisM Ruhnke, M Trautmann, K Borner, et al.
Transplantation Proceedings|December 26, 2001
Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantationC Jung, E Engelmann, K Borner, et al.
International Journal of Antimicrobial Agents|July 1, 1994
Use of fluoroquinolones in lower respiratory tract infections (LRTI)H Lode, T Schaberg, G Höffken, et al.
Zentralblatt Fur Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie Und Parasitologie|May 1, 1971
[Growth increase of a permanent tissue culture cell line cultivated in a lactalbumin-yeast-medium reached by additional supply with nutritive material]R Averdunk, K Borner, F Da Fonseca-Willheim
The American Journal of Medicine|November 30, 1989
Ciprofloxacin intravenous dose varianceH Lode, G Hoffken, K Borner, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patientsD Kampf, K Borner, H Hain, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 1, 1997
Dosage adjustment of antiinfective therapy in patients with renal impairmentA Eckhardt, K Borner, F Keller, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1996
Azithromycin--review of key chemical, pharmacokinetic and microbiological featuresH Lode, K Borner, P Koeppe, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|January 1, 1984
Comparative pharmacokinetics of apalcillin and piperacillinH Lode, A Elvers, P Koeppe, et al.
Clinical Pharmacology and Therapeutics|February 1, 1984
Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal functionD Kampf, K Borner, M Möller, et al.
Chemotherapy|January 1, 1990
Pharmacokinetics of ciprofloxacin in liver cirrhosisM Ruhnke, M Trautmann, K Borner, et al.
Transplantation Proceedings|December 26, 2001
Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantationC Jung, E Engelmann, K Borner, et al.
International Journal of Antimicrobial Agents|July 1, 1994
Use of fluoroquinolones in lower respiratory tract infections (LRTI)H Lode, T Schaberg, G Höffken, et al.
Zentralblatt Fur Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie Und Parasitologie|May 1, 1971
[Growth increase of a permanent tissue culture cell line cultivated in a lactalbumin-yeast-medium reached by additional supply with nutritive material]R Averdunk, K Borner, F Da Fonseca-Willheim
The American Journal of Medicine|November 30, 1989
Ciprofloxacin intravenous dose varianceH Lode, G Hoffken, K Borner, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patientsD Kampf, K Borner, H Hain, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 1, 1997
Dosage adjustment of antiinfective therapy in patients with renal impairmentA Eckhardt, K Borner, F Keller, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1996
Azithromycin--review of key chemical, pharmacokinetic and microbiological featuresH Lode, K Borner, P Koeppe, et al.
Pageof 11